PHIBRO ANIMAL HEALTH CORP financial data

Symbol
PAHC on Nasdaq
Location
Teaneck, NJ
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 298% % -4.1%
Quick Ratio 169% % 15%
Debt-to-equity 382% % 42%
Return On Equity 24% % 271%
Return On Assets 5% % 184%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $422,641,765 USD 80%
Weighted Average Number of Shares Outstanding, Basic 40,534,000 shares 0.07%
Weighted Average Number of Shares Outstanding, Diluted 40,877,000 shares 0.73%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,399,676,000 USD 34%
Operating Income (Loss) $144,026,000 USD 101%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $94,640,000 USD 191%
Income Tax Expense (Benefit) $26,824,000 USD 78%
Net Income (Loss) Attributable to Parent $67,816,000 USD 290%
Earnings Per Share, Basic 1 USD/shares 288%
Earnings Per Share, Diluted 1 USD/shares 288%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $72,769,000 USD 40%
Accounts Receivable, after Allowance for Credit Loss, Current $217,896,000 USD 36%
Inventory, Net $471,775,000 USD 73%
Other Assets, Current $60,855,000 USD 28%
Assets, Current $835,799,000 USD 46%
Other Long-term Investments $8,350,000 USD
Deferred Income Tax Assets, Net $23,544,000 USD -7.8%
Property, Plant and Equipment, Net $354,780,000 USD 72%
Operating Lease, Right-of-Use Asset $40,146,000 USD 6.9%
Goodwill $59,708,000 USD 9.4%
Other Assets, Noncurrent $100,273,000 USD 9.4%
Assets $1,385,524,000 USD 43%
Accounts Payable, Current $130,597,000 USD 51%
Employee-related Liabilities, Current $37,216,000 USD 24%
Liabilities, Current $270,139,000 USD 53%
Deferred Income Tax Liabilities, Net $4,197,000 USD 529%
Operating Lease, Liability, Noncurrent $33,116,000 USD 11%
Other Liabilities, Noncurrent $79,186,000 USD 23%
Liabilities $1,073,843,000 USD 52%
Accumulated Other Comprehensive Income (Loss), Net of Tax $120,021,000 USD 3.2%
Retained Earnings (Accumulated Deficit) $294,364,000 USD 20%
Stockholders' Equity Attributable to Parent $311,681,000 USD 21%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $311,681,000 USD 21%
Liabilities and Equity $1,385,524,000 USD 43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,302,000 USD -26%
Net Cash Provided by (Used in) Financing Activities $16,335,000 USD
Net Cash Provided by (Used in) Investing Activities $21,014,000 USD -617%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,730,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $72,769,000 USD 40%
Deferred Tax Assets, Valuation Allowance $1,279,000 USD -0.7%
Deferred Tax Assets, Gross $59,609,000 USD 46%
Operating Lease, Liability $42,867,000 USD 15%
Depreciation $42,141,000 USD 57%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $71,730,000 USD 1558%
Lessee, Operating Lease, Liability, to be Paid $51,926,000 USD 15%
Property, Plant and Equipment, Gross $633,650,000 USD 41%
Operating Lease, Liability, Current $9,021,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,157,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year One $10,151,000 USD 15%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,059,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,232,000 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 16,000,000 shares 0%
Unrecognized Tax Benefits $12,470,000 USD 5.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,459,000 USD 14%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $7,290,000 USD -23%
Depreciation, Depletion and Amortization $49,431,000 USD 36%
Deferred Tax Assets, Net of Valuation Allowance $58,330,000 USD 48%
Interest Expense $22,460,000 USD 35%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%